teratogenic exposures and evaluating the effectiveness of primary prevention policies (Dolk, 2005) . 96
Surveillance of congenital anomalies is often performed using defined sets of subgroups, such as the 97 EUROCAT anomaly subgroups (EUROCAT, 2005) . Many of these subgroups overlap, for example the 98 congenital heart defects (CHD) subgroup includes further subgroups such as ventricular septal 99 defects, atrial septal defects and tetralogy of Fallot (ToF). Despite known relationships amongst 100 many of the subgroups, current surveillance methods examine trends, clusters or associations 101 between risk factors and anomalies within each subgroup separately (EUROCAT, 2015; Loane and 102 others, 2011b). Relevant information on relationships between anomalies across the different 103 subgroups is therefore not currently being incorporated in surveillance analyses; hence it is possible 104 that important associations or trends are not being detected by the current methods. Congenital 105 anomaly surveillance methods that combine information from several subgroups simultaneously 106 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Methods

111
EUROCAT dataset 112
This study is based on routinely collected EUROCAT data from 18 full member registries in 11 113 anomaly into 89 EUROCAT anomaly subgroups. EUROCAT anomaly subgroups are grouped in a 123 hierarchical structure, with the highest level being the major organ groups, within which there are 124 further classes. Spina bifida, for example, is in the neural tube defects (NTD) subgroup, which is 125 within the Nervous System group of anomalies. A case may be counted only once in each of the 126 lowest level EUROCAT subgroups, but if it has multiple anomalies it will be counted in multiple 127 subgroups. Cases with genetic conditions (genetic syndromes/ microdeletions, teratogenic 128 syndromes with malformations, or chromosomal anomalies) were excluded from all analyses of non-129 chromosomal anomaly. Data are collected for all birth outcomes, including live and still births and 130 terminations of pregnancy for fetal anomaly. Further details regarding the registries, methods of 131 that includes the grouping of CHDs by these severity subgroups was also considered. A data-level 147 variance component was used to directly model potential overdispersion in the data for hierarchical 148 models (Gelman and Hill, 2007) . Models were also repeated with the inclusion of a term to take 149 account of the random effects of registry. All statistical analyses were conducted in R (R 150 Development Core Team, 2008). Markov Chain Monte Carlo sampling methods were used to obtain 151 estimates of variability around the random effects in hierarchical models by using Gibbs sampling 152 (Casella and George, 1992) in the Bayesian analysis programme JAGS via the R package rjags 153 . Results from hierarchical models are presented as annual percentage changes in 154 prevalence and their 95% posterior credible intervals (PCIs), which can be thought of as the Bayesian 155 equivalent of 95% confidence intervals (CIs) and where we say there is a 95% probability that the 156 consider this a "statistically significant" average annual change in prevalence or a "signal". The 158 resulting estimates are only valid if convergence has occurred, which is assessed graphically and by 159 using convergence diagnostics in the R package coda (Plummer and others, 2003) . Further details on 160 the use of the Bayesian hierarchical models in JAGs can be found in the Appendix. 161
Results
162
A total of 103,507 cases of congenital anomaly (81,147 cases excluding genetic conditions) were 163 available for analysis from a combined population of 4,097,142 births over 18 registries during the 164 10 year study period. Trends were assessed in 4,167 NTD, 13,358 chromosomal, 25,273 CHD and 165 7,683 digestive system anomaly cases ( Table 1) . The rarest subgroup included in these analyses was 166
the digestive system anomaly annular pancreas, with only 57 cases in the combined population over 167 the ten years giving an estimated total prevalence of 0.1 cases per 10,000 births. The most common 168 anomaly subgroup was the CHD ventricular septal defect, with an estimated total prevalence of 169 almost 28 cases per 10,000 births ( Table 1) . 170
Models for neural tube defects 171
There were no changes in prevalence for any of the NTD subgroups, with estimated average annual 172 trends remaining very similar for individual and hierarchical models and 95% CIs and PCIs including 173 zero (no change) for all estimates (Figure 1 ). There was some "shrinkage" in the estimates towards 174 the group mean in the hierarchical model, in particular for encephalocele, although this estimated 175 trend was not significant in either model. 176
Models for chromosomal anomalies 177
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where the hierarchical classification systems may provide more natural hierarchies than the 249 grouping of anomalies according to the defined subgroups. Indeed, the EUROCAT subgroup coding 250 hierarchy provides sets of anomalies that are too heterogeneous in practice to be grouped together 251 when analysing changes in prevalence. This is because the "shrinkage", a key feature of hierarchical 252 models (Gelman and Hill, 2007) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 subgroups is close to the null, this penalisation will mean that the estimated trend is no longer a 263 "signal" in the hierarchical model, for example as seen for the CHD ToF in severity group II (Figure 3) . 264
For a group where the mean trend is not so close to the null, however, this penalisation might 265 actually lead to an increase in the strength and precision of a signal, for example for ASD in severity 266 group III (Figure 3) . Furthermore, the same signal might be reduced or enhanced depending on 267 which grouping is used; for example, the trend in PVS is attenuated if considering all CHD groups 268 together but maintained if also including the severity grouping in the hierarchical model (Figure 3) . 269
This highlights how the posterior distribution is sensitive to the prior information, which here is the 270 way the groups have been defined. 271
EUROCAT subgroups that were considered to be related, for example aetiologically similar or in the 272 same organ system class, were still found to vary considerably in terms of their differing 273 proportional yearly changes in prevalence. It is well known (Gelman and Hill, 2007; Greenland, 274 2000) , and has been seen here in the case of NTDs and autosomal trisomy groups of anomalies, that 275 a random effects model with only three levels for the random effect parameter does not perform 276 well, with such models showing poor convergence and over-parameterisation. There may be other 277 larger groups of anomalies that are similar enough to be analysed together that were not considered 278 here, and in fact there are known relationships between anomalies that lie within different groups of 279 the EUROCAT hierarchy. In addition to NTDs, for example, there are a number of other anomalies 280 across different body systems that are known to be sensitive to folate levels during pregnancy, 281 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Strengths and limitations of this study 297
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